Vimta Labs Limited (VIMTALABS) - Total Assets

Latest as of March 2026: Rs5.62 Billion INR ≈ $60.80 Million USD

Based on the latest financial reports, Vimta Labs Limited (VIMTALABS) holds total assets worth Rs5.62 Billion INR (≈ $60.80 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Vimta Labs Limited - Total Assets Trend (2006–2026)

This chart illustrates how Vimta Labs Limited's total assets have evolved over time, based on quarterly financial data. Also see how much is Vimta Labs Limited worth for the company's overall valuation and market capitalisation.

Vimta Labs Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Vimta Labs Limited's total assets of Rs5.62 Billion consist of 40.0% current assets and 60.0% non-current assets. Review VIMTALABS total debt and obligations to assess the company's total debt and financial obligations.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 11.6%
Accounts Receivable Rs1.06 Billion 18.8%
Inventory Rs299.47 Million 5.3%
Property, Plant & Equipment Rs0.00 0.0%
Intangible Assets Rs49.29 Million 0.9%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2006–2026)

This chart illustrates how Vimta Labs Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Vimta Labs Limited for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Vimta Labs Limited's current assets represent 40.0% of total assets in 2026, a decrease from 56.6% in 2006.
  • Cash Position: Cash and equivalents constituted 11.6% of total assets in 2026, up from 4.2% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
  • Asset Diversification: The largest asset category is accounts receivable at 18.8% of total assets.

Vimta Labs Limited Competitors by Total Assets

Key competitors of Vimta Labs Limited based on total assets are shown below.

Company Country Total Assets
Fleury S.A.
SA:FLRY3
Brazil R$13.56 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
Bionet
TWO:1784
Taiwan NT$3.08 Billion
Scope Fluidics SA
WAR:SCP
Poland zł141.67 Million
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$16.78 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion

Vimta Labs Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.43 2.92 2.05
Quick Ratio 2.97 2.53 1.78
Cash Ratio 0.00 0.51 0.00
Working Capital Rs1.59 Billion Rs1.23 Billion Rs566.25 Million

Vimta Labs Limited - Advanced Valuation Insights

This section examines the relationship between Vimta Labs Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 6.37
Latest Market Cap to Assets Ratio 0.05
Asset Growth Rate (YoY) 20.5%
Total Assets Rs5.62 Billion
Market Capitalization $289.62 Million USD

Valuation Analysis

Below Book Valuation: The market values Vimta Labs Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Vimta Labs Limited's assets grew by 20.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Vimta Labs Limited (2006–2026)

The table below shows the annual total assets of Vimta Labs Limited from 2006 to 2026.

Year Total Assets Change
2026-03-31 Rs5.62 Billion
≈ $60.80 Million
+20.51%
2025-03-31 Rs4.67 Billion
≈ $50.45 Million
+16.62%
2024-03-31 Rs4.00 Billion
≈ $43.26 Million
+10.41%
2023-03-31 Rs3.62 Billion
≈ $39.18 Million
+17.95%
2022-03-31 Rs3.07 Billion
≈ $33.22 Million
+11.97%
2021-03-31 Rs2.74 Billion
≈ $29.67 Million
+11.63%
2020-03-31 Rs2.46 Billion
≈ $26.58 Million
+3.51%
2019-03-31 Rs2.37 Billion
≈ $25.68 Million
+2.23%
2018-03-31 Rs2.32 Billion
≈ $25.12 Million
+4.79%
2017-03-31 Rs2.22 Billion
≈ $23.97 Million
+26.22%
2016-03-31 Rs1.76 Billion
≈ $18.99 Million
+19.99%
2015-03-31 Rs1.46 Billion
≈ $15.83 Million
-1.80%
2014-03-31 Rs1.49 Billion
≈ $16.12 Million
+3.06%
2013-03-31 Rs1.45 Billion
≈ $15.64 Million
-7.56%
2012-03-31 Rs1.56 Billion
≈ $16.92 Million
-11.39%
2011-03-31 Rs1.77 Billion
≈ $19.09 Million
-2.92%
2010-03-31 Rs1.82 Billion
≈ $19.67 Million
+7.09%
2009-03-31 Rs1.70 Billion
≈ $18.36 Million
-1.59%
2008-03-31 Rs1.73 Billion
≈ $18.66 Million
-0.78%
2007-03-31 Rs1.74 Billion
≈ $18.81 Million
+1.81%
2006-03-31 Rs1.71 Billion
≈ $18.47 Million
--

About Vimta Labs Limited

NSE:VIMTALABS India Diagnostics & Research
Market Cap
$289.62 Million
Rs26.78 Billion INR
Market Cap Rank
#15110 Global
#762 in India
Share Price
Rs599.30
Change (1 day)
+0.30%
52-Week Range
Rs380.70 - Rs748.20
All Time High
Rs1155.00
About

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more